Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 19-Sep-24
Select bar for recommendation details.
Recommendations | 19-Sep-24 | |
---|---|---|
Buy | 2 | |
Outperform | 5 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 7 analysts offering 12 month price targets for Outlook Therapeutics Inc have a median target of 33.00, with a high estimate of 53.00 and a low estimate of 25.00. The median estimate represents a 450.00% increase from the last price of 6.00.
High | 783.3% | 53.00 |
Med | 450.0% | 33.00 |
Low | 316.7% | 25.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Dec 20, 2024.
Average growth rate | -188.53% |
Average growth rate | +31.93% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
Average growth rate | -25.00% |
More ▼